E. Hasimbegovic

发表

A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome

G. Garhöfer, K. Schmetterer, M. Gyöngyösi, 2022, iScience.

Identification of Gene Expression Signatures for Phenotype-Specific Drug Targeting of Cardiac Fibrosis

F. Zannad, M. Gyöngyösi, T. Thum, 2023, International journal of molecular sciences.

Large Animal Models of Cell-Free Cardiac Regeneration

M. Gyöngyösi, G. Goliasch, N. Pavo, 2020, Biomolecules.

Alternative Splicing in Cardiovascular Disease—A Survey of Recent Findings

M. Gyöngyösi, Julia Mester-Tonczar, A. Spannbauer, 2021, Genes.

Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome

E. Puchhammer-Stöckl, C. Loewe, M. Gyöngyösi, 2023, NPJ vaccines.

Circular RNAs in Cardiac Regeneration: Cardiac Cell Proliferation, Differentiation, Survival, and Reprogramming

M. Gyöngyösi, G. Goliasch, N. Pavo, 2020, Frontiers in Physiology.

New Insights and Current Approaches in Cardiac Hypertrophy Cell Culture, Tissue Engineering Models, and Novel Pathways Involving Non-Coding RNA

M. Gyöngyösi, Julia Mester-Tonczar, A. Spannbauer, 2020, Frontiers in Pharmacology.

Preclinical development of a miR-132 inhibitor for heart failure treatment

M. Mayr, M. Gyöngyösi, J. Viereck, 2020, Nature Communications.

Non-Coding RNAs in Stem Cell Regulation and Cardiac Regeneration: Current Problems and Future Perspectives

M. Gyöngyösi, Julia Mester-Tonczar, A. Spannbauer, 2021, International journal of molecular sciences.

Deviations From the Ideal Plasma Volume and Isolated Tricuspid Valve Surgery—Paving the Way for New Risk Stratification Parameters

B. Hofer, G. Laufer, D. Wiedemann, 2022, Frontiers in Cardiovascular Medicine.

A Sneak-Peek into the Physician’s Brain: A Retrospective Machine Learning-Driven Investigation of Decision-Making in TAVR versus SAVR for Young High-Risk Patients with Severe Symptomatic Aortic Stenosis

L. Papp, M. Grahovac, G. Delle-Karth, 2021, Journal of personalized medicine.

Plasma Small Extracellular Vesicle Cardiac miRNA Expression in Patients with Ischemic Heart Failure, Randomized to Percutaneous Intramyocardial Treatment of Adipose Derived Stem Cells or Placebo: Subanalysis of the SCIENCE Study

M. Gyöngyösi, Julia Mester-Tonczar, A. Spannbauer, 2023, International journal of molecular sciences.

Improvement of Symptoms and Cardiac Magnetic Resonance Abnormalities in Patients with Post-Acute Sequelae of SARS-CoV-2 Cardiovascular Syndrome (PASC-CVS) after Guideline-Oriented Therapy

M. Gyöngyösi, A. Spannbauer, K. Zlabinger, 2023, Biomedicines.

Transcatheter versus Isolated Surgical Aortic Valve Replacement in Young High-Risk Patients: A Propensity Score-Matched Analysis

C. Gross, G. Delle-Karth, A. Schober, 2021, Journal of clinical medicine.

CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure

M. Gyöngyösi, J. Viereck, T. Thum, 2020, European heart journal.

Association between Circular RNA CDR1as and Post-Infarction Cardiac Function in Pig Ischemic Heart Failure: Influence of the Anti-Fibrotic Natural Compounds Bufalin and Lycorine

M. Gyöngyösi, T. Thum, S. Batkai, 2020, Biomolecules.

Identifying Patients without a Survival Benefit following Transfemoral and Transapical Transcatheter Aortic Valve Replacement

G. Delle-Karth, M. Grabenwöger, M. Mach, 2021, Journal of clinical medicine.

Multi-omics provide evidence for an anti-inflammatory immune signature and metabolic alterations in patients with Long COVID Syndrome; an exploratory study

K. Schmetterer, J. Kovarik, A. Bileck, 2022, medRxiv.